Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bettera Brands is a leading contract development and manufacturing organization (CDMO) specializing in the consumer health and wellness sector. The company provides end-to-end services for the formulation and production of vitamins, minerals, and supplements in gummy, lozenge, and soft chew formats. Operating multiple high-capacity manufacturing facilities across the United States, Bettera utilizes advanced pectin and gelatin-based technologies to serve global brands. The company was formed through the strategic merger of several specialized manufacturers under the ownership of Highlander Partners. In 2021, Catalent acquired Bettera Brands for $1 billion to significantly expand its presence in the high-growth nutraceutical market. Today, it operates as a key component of Catalent's consumer health business unit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bettera.